Establishment Labs Financial Ratios

NASDAQ: ESTAHealth CareIndustrial SpecialtiesUSD

61.67+1.06 (+1.75%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Establishment Labs ratio analysis

Establishment Labs earned a net margin of -24.2% in FY 2025, up from -51.0% a year earlier. Gross margin was 69.3% compared with a median of 63.4% over the prior 8 years. Return on equity reached -216.9%, meaning Establishment Labs generated -2.17 dollars of profit for every dollar of shareholders' equity.

Debt-to-equity stood at 10.51 versus 4.14 the year before, and the current ratio was 3.04. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Establishment Labs financial ratios (annual)

Establishment Labs annual financial ratios
Ratio	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Price / sales	9.66	7.85	4.01	9.93	12.79	10.36	6.53	7.37	—
Price / book	86.59	24.54	36.03	—	31.93	11.71	14.76	6.49	—
Gross margin	69.3%	66.0%	64.8%	65.9%	67.4%	62.0%	61.3%	59.0%	51.0%
Operating margin	-18.5%	-30.1%	-39.4%	-24.5%	-19.8%	-33.0%	-34.5%	-39.0%	-57.6%
Net margin	-24.2%	-51.0%	-47.5%	-46.5%	-32.5%	-45.0%	-42.6%	-34.5%	-100.6%
Free cash flow margin	-27.0%	-38.9%	-58.4%	-34.0%	-23.6%	-17.3%	-40.5%	-58.2%	-94.8%
Return on equity (ROE)	-216.9%	-159.3%	-426.8%	—	-81.1%	-50.9%	-96.3%	-30.4%	—
Return on assets (ROA)	-14.3%	-24.4%	-29.2%	-35.6%	-29.5%	-24.4%	-32.7%	-18.1%	-61.1%
Debt / equity	10.51	4.14	10.26	—	1.02	0.66	1.22	—	—
Current ratio	3.04	3.56	3.06	3.85	3.55	5.11	4.12	6.05	0.69
Revenue growth	27.1%	0.5%	2.1%	27.6%	49.6%	-5.5%	46.3%	76.5%	—